Randomized controlled trials |
---|
Amornpetchakul et al. 2018, Thailand15 | RCT, triple-blind, single-centre
Registration: TCTR20160715004 | 350 singleton pregnant patients
Age ≥ 35 years: 19 and 26 of the oxytocin (n = 174) and carbetocin (n = 176) respectively
Mean gestational age (weeks): 38.4 ± 1.2 and 38.5 ±1.3 respectively
Inclusion criteria: 20 years or older, a gestational age of at least 34 weeks, a vaginal delivery, and at least one risk factor for atonic post-partum hemorrhage
At least one risk factors of atonic PPH needed for inclusion: “(1) a previous history of PPH; (2) induction or augmentation of labor > 4 h; (3) exposure to tocolytic agents within 4 h prior to delivery; (4) a prolonged active phase of labor > 12 h; (5) precipitated labor; (6) grand multipara (parity > 4); (7) polyhydramnios; and (8) presence of uterine leiomyoma” (p. 320) | 100 μg of carbetocin
versus
5 U of oxytocin intravenously
Immediately after childbirth but before placental delivery | Postpartum blood loss, incidence of atonic PPH, usage of additional uterotonic drugs, and incidence of postpartum anemia |
Mannaerts et al. 2018, Belgium16 | RCT, double-blind, single-centre
Registration: ISRCTN 95504420 | 68 patients
Inclusion criteria: “singleton pregnancies undergoing a planned cesarean section at term (≥37 weeks) under combined spinal/epidural anaesthesia” (p. 2)
Gestational ages: 38 to 40 weeks. | 100 μg of carbetocin (Pabal®, Ferring NV, Aalst, Belgium) single dose over 3 minutes
versus
oxytocin (Syntocinon, Sigma-Tau, Rome, Italy), 5 IU over 3 minutes followed by 10 IU oxytocin over 24 hours | Nausea, vomiting, blood pressure, heart rate, nausea/vomitus, need for vasopressors, preoperative and postoperative haemoglobin and haematocrit levels
Follow-up 48 hours |
Taheripanah et al. 2018, Iran20 | RCT, two-centre, double-blind
Registration: NCT02079558 | 220 patients
Mean age (years) in 2 groups: 27.69 ± 5.7 and 26.93 ±5.4, P = 0.643
Gestational age > 37 weeks
Inclusion criteria: “presence of at least one risk factor for postpartum hemorrhage among patients who could not give birth and then underwent emergency cesarean delivery (prolonged third stage of labor, mediolateral episiotomy, previous postpartum hemorrhage, arrest of descent, soft-tissue lacerations, augmented labor, forceps or vacuum delivery, Asian or Hispanic ethnicity, midline episiotomy, and nulliparity), and lack of hyper sensitivity to oxytocin and carbetocin” (p. 2808) | Single 100 μg IV dose of carbetocin
versus
30-international unit IV infusion of oxytocin during 2 hours after delivery of placenta | Postpartum hemorrhage requiring additional uterotonic drugs, bleeding volume, and the hemoglobin drops |
Widmer et al. 2018, Switzerland5 | RCT, multi-centre (10 countries), double-blind, non-inferiority, active-controlled
Carbetocin Haemorrhage Prevention (CHAMPION)
Registration: ACTRN12614000870651; EudraCT 2014-004445-26 and, CTRI/ 2016/ 05/ 006969.) | 29,645 patients randomized
29,539 modified intent-to-treat patients
Median age: 25 years
Median gestational age: 39 weeks
Inclusion criteria: “Women who expected to give birth vaginaiiy and who had a singleton pregnancy and cervical dilatation of 6 cm or less” (p. 745) | Heat-stable carbetocin (at a dose of 100 μg)
versus
oxytocin (at a dose of 10 IU)
immediately after vaginal birth | Primary outcomes: proportion of patients with blood loss of at least 500 ml or the use of additional uterotonic agents, and the proportion of patients with blood loss of at least 1,000 ml
Secondary outcomes “proportion of women with blood loss of at least 1000 ml at 1 hour and up to 2 hours for women who continued to bleed after 1 hour” (p. 746) |
Elbohoty et al. 2016, Egypt17 | RCT, double-blind, single-centre
Registration: NCT02053922 | 263 patients undergoing an elective cesarean delivery
Inclusion criteria: singleton pregnancy, full term (duration of pregnancy ≥37 weeks) | Carbetocin: single 100 μg (Pabal; Draxis/Multipharma, Egypt) following the delivery
versus
oxytocin single 10 IU (Syntocinon; Novartis Pharma, Berne, Switzerland) slowly intravenously following neonatal delivery with 20 IU oxytocin intravenous infusion over 4 hours
versus
misoprostol: two tablets (each tablet 200 μg) (Misotac; Sigma Pharmaceuticals, Egypt) following the cesarean delivery | Primary outcome: occurrence of uterine atony necessitating additional uterotonics
Secondary outcomes: total blood loss, the difference in hemoglobin level before and 24 hours after delivery, and the development of any adverse events |
Fahmy, Yousef, and Zaki 2016, Egypt18 | RCT, single-centre, single blind (clinicians) | 60 multiple pregnancy patients undergoing elective cesarean delivery
Gestational age: not reported
Inclusion criteria: twin pregnancy patients ASA physical status I, and aged 28 to 36 years | 100 μg carbetocin
versus
20 IU oxytocin | Need for methylergometrine postoperative, blood loss, blood pressure, and heart rates |
Kabir et al. 2015, Bangladesh19 | RCT, single-centre, no blinding reported | 94 pregnant patients undergoing vaginal deliveries
Inclusion criteria: “women with a single pregnancy undergoing vaginal delivery above 36 weeks of gestation (gestational age was recorded according to the last menstrual period and was confirmed by ultrasound report)” (p. 4) | Intravenous 100 micro gram carbetocin
versus
intramuscular 10 IU oxytocin in third stage of labour. | Massive blood loss, primary PPH, blood transfusion, additional uterotonics, adverse effects |
Non-randomized studies |
---|
Chen et al. 2018, Taiwan21 | Retrospective cohort study, single-centre | 1,568 patients with cesarean deliveries
“before labor onset (elective CS, n = 1,153) or during labor (intrapartum CS, n = 415) after 24 weeks’ gestation” (p. 677)
Mean ages of 4 groups: 33.1 to 35.0 years
Ranges of mean gestational ages: 36.9 to 38.7 weeks in 4 groups | Carbetocin (100 mg intravenously infused over 1 min)
versus
oxytocin (10 units as a bolus, intravenously infused) administration after delivering the newborn
“then received intravenous infusion of oxytocin at a rate of 1.0 - 1.2 units per hour until the next morning to control for the operative hemorrhage” (p. 677) | Fall in hemoglobin and hematocrit levels after CS, estimated blood loss, need for additional uterotonic agents, blood transfusion, and rate of postpartum hemorrhage |
Sotillo et al. 2018, Spain22 | Prospective cohort study, single-centre | 166 twin pregnancies at term undergoing elective or emergency cesarean section
Inclusion criteria: “patients older than 18 years, elective or nonelective cesarean performed in twin gestations over 24 weeks, cesarean section performed through low segment hysterotomy absence of maternal contraindications for the use of carbetocin (serious cardiovascular disorders, liver or kidney failure, and/or eclampsia), and cesarean section under epidural or spinal anesthesia” (p. 2) | Single 100 μg dose of carbetocin
versus
oxytocin 20 IU in 10 to 15 min | “intraoperative bleeding (estimated by the anesthetist from the amount of blood collected in the aspirator and the number of compresses used during the intervention), surgical time (from the skin incision to the skin closure), hemoglobin fall, hematocrit drop, additional uterotonic use (Methylergometrine and/or misoprostol), need for blood transfusion, and/or IV iron therapy” (p. 2)
“proportion of patients who needed additional treatments during the postpartum period, understanding as such the need for additional uterotonic (Methylergometrine and/or misoprostol) and/or the need for treatment for anemia (IV iron therapy and/or blood transfusion)” (p. 2) |
Wohling et al. 2018, Australia23 | Retrospective cohort study, single-centre, before-and-after | 2,499 singleton pregnancies undergoing CS from 2008 to 2010
Mean maternal ages: 29.2 ± 5.8 and 29.0 ± 5.9 years
Mean gestational ages: 38.6 and 38.7 weeks in 2 groups | Prophylactic oxytocin 5 to 10 units slow push intravenously at delivery from January 2008 to 24 March 2009
versus
100 μg intravenous carbetocin after 24 March 2009, until 2010 | PPH (≥1000mL) and the requirement of secondary uterotonics |
Seow et al. 2017, Taiwan25 | Cohort study, single-centre | 64 patients
Mean ages: 34.5 ± 4.2 and 33.7 ± 3 years, carbetocin and control respectively (P > 0.05)
Mean gestational age: 35.2 weeks
Cesarean delivery: all
Inclusion criteria: “twin pregnancy induced using in vitro fertilization-embryo transfer (IVF-ET)” (p. 274) | 100 μg carbetocin intravenously, single dose, as soon as the baby was delivered but before the placenta was delivered
versus
continuous IV infusion of 10 IU oxytocin as soon as the baby was delivered and for 24 h afterward | Primary outcome: drop in hemoglobin level by comparing the maternal hemoglobin concentration on admission before cesarean delivery with that measured 24 h after delivery
Secondary outcomes: “blood loss during surgery, and lochia within 2 h after delivery, the duration of the operation, the incidence of primary PPH (defined as blood loss more than 1000 ml), and blood transfusion” (p. 274)
Blood loss: estimated after excluded amniotic fluid volume in each case
Maternal pulse rate and fetal body weight, and need for additional uterotonic agents |
Nucci et al. 2016, France24 | Retrospective cohort study, single-centre, before-and-after | 60 patients with severe preeclampsia undergoing cesarean delivery under spinal anaesthesia, ASA 3
Mean gestational age: 31.8 and 31.9 weeks
Sever preeclampsia: 2009 French Society of Anesthesiology and Critical Care Medicine guideline | 100 μg intravenous carbetocin
(first 18 months between July 2011 and August 2013)
versus
5 IU oxytocin (last 8 months between the same period) after the birth of the infant | Need for additional uterotonics, time interval to additional uterotonics, need for compression balloon, hemoglobin difference, loss of hemoglobin, need for blood products, red blood cells, fresh frozen plasma, and admission to intensive care unit |